Literature DB >> 19474242

Transduction of vertebrate cells with Spodoptera exigua multiple nucleopolyhedrovirus F protein-pseudotyped gp64-null Autographa californica multiple nucleopolyhedrovirus.

Ian-Ling Yu1, Ying-Chu Lin, John H Robinson, Oliver Lung.   

Abstract

Budded virions of the baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) can enter a variety of non-host cells. The capacity of GP64, AcMNPV's endogenous envelope fusion protein, and SeF, the fusion protein from a gp64(-) baculovirus, to mediate baculovirus entry into vertebrate cells was examined by comparing the transduction efficiencies of engineered AcMNPV variants with either of the two envelope proteins into 17 vertebrate cell lines. At an m.o.i. of 500, GP64-expressing viruses transduced all cell lines with varying efficiencies. Transduction efficiencies of SeF-pseudotyped gp64-null AcMNPV into all cell lines were lower than those of GP64-expressing viruses, and were undetectable in seven cell lines. At an m.o.i. of 50, transduction of all mammalian cell lines transducible by the SeF-pseudotyped gp64-null AcMNPV at an m.o.i. of 500 was no longer detectable. An amplifiable SeF-pseudotyped gp64-null AcMNPV vector with greatly reduced tropism for vertebrate cells may have applications in engineering AcMNPV for targeted transduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474242     DOI: 10.1099/vir.0.012138-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Baculovirus as a vaccine vector.

Authors:  Hsin-Yu Lu; Yi-Hsuan Chen; Hung-Jen Liu
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

2.  Genome Characteristics of the Cyclophragma Undans Nucleopolyhedrovirus: A Distinct Species in Group I of Alphabaculovirus.

Authors:  Zheng Zhu; Jun Wang; Qianran Wang; Feifei Yin; Xiaoping Liu; Dianhai Hou; Lei Zhang; Haizhou Liu; Jiang Li; Basil M Arif; Hualin Wang; Fei Deng; Zhihong Hu; Manli Wang
Journal:  Virol Sin       Date:  2018-08-28       Impact factor: 4.327

3.  A Betabaculovirus-Encoded gp64 Homolog Codes for a Functional Envelope Fusion Protein.

Authors:  Daniel M P Ardisson-Araújo; Fernando L Melo; Rollie J Clem; José L C Wolff; Bergmann M Ribeiro
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

4.  Seamless replacement of Autographa californica multiple nucleopolyhedrovirus gp64 with each of five novel type II alphabaculovirus fusion sequences generates pseudotyped virus that fails to transduce mammalian cells.

Authors:  Marcel Westenberg; Helen M Soedling; Nisha Hirani; Linda J Nicholson; Derek A Mann; Colin T Dolphin
Journal:  J Gen Virol       Date:  2012-04-04       Impact factor: 3.891

5.  Counter-selection recombineering of the baculovirus genome: a strategy for seamless modification of repeat-containing BACs.

Authors:  Marcel Westenberg; Helen M Soedling; Derek A Mann; Linda J Nicholson; Colin T Dolphin
Journal:  Nucleic Acids Res       Date:  2010-07-09       Impact factor: 16.971

Review 6.  Baculovirus as a Tool for Gene Delivery and Gene Therapy.

Authors:  Chikako Ono; Toru Okamoto; Takayuki Abe; Yoshiharu Matsuura
Journal:  Viruses       Date:  2018-09-19       Impact factor: 5.048

Review 7.  Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.

Authors:  Chi-Yuan Chen; Chin-Yu Lin; Guan-Yu Chen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2011-04-28       Impact factor: 14.227

Review 8.  Baculoviruses in Gene Therapy and Personalized Medicine.

Authors:  Sabrina Schaly; Merry Ghebretatios; Satya Prakash
Journal:  Biologics       Date:  2021-04-28

9.  A betabaculovirus encoding a gp64 homolog.

Authors:  Daniel M P Ardisson-Araújo; Bruna T Pereira; Fernando L Melo; Bergmann M Ribeiro; Sônia N Báo; Paolo M de A Zanotto; Flávio Moscardi; Elliot W Kitajima; Daniel R Sosa-Gomez; José L C Wolff
Journal:  BMC Genomics       Date:  2016-02-04       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.